Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1314)	7/25/2005 11:54:15 PM
From: Jibacoa	Respond to of 3722

NEXM has continued the near term uptrend that started on July 14 from the 1.35 level. Today the stock traded for a while above its October 2004 H of 1.81, but it closed 2 cent below it.<g> The stock was up 11,88% on volume of 539,815 (That was better than its daily average but below the 793,073 traded on July 19 which was also an upday.) bigcharts.marketwatch.com NEXM joined the Russell Microcap Index earlier this month. There were some insiders buying in March and April. The loss for the 1st Q was a penny below the loss in 2004 Its main research is on transdermal medications and its lead product is one for men with ED. It is also working on another transdermal for female SD as well as transdermals for arthritis,asthma, nausea & vomiting, among others. Looking it from a longer term perspective, its chart seems to have some potential.<g> bigcharts.marketwatch.com Bernard